Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 19;8(12):e39141.
doi: 10.2196/39141.

Representativeness, Vaccination Uptake, and COVID-19 Clinical Outcomes 2020-2021 in the UK Oxford-Royal College of General Practitioners Research and Surveillance Network: Cohort Profile Summary

Affiliations

Representativeness, Vaccination Uptake, and COVID-19 Clinical Outcomes 2020-2021 in the UK Oxford-Royal College of General Practitioners Research and Surveillance Network: Cohort Profile Summary

Meredith Leston et al. JMIR Public Health Surveill. .

Abstract

Background: The Oxford-Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) is one of Europe's oldest sentinel systems, working with the UK Health Security Agency (UKHSA) and its predecessor bodies for 55 years. Its surveillance report now runs twice weekly, supplemented by online observatories. In addition to conducting sentinel surveillance from a nationally representative group of practices, the RSC is now also providing data for syndromic surveillance.

Objective: The aim of this study was to describe the cohort profile at the start of the 2021-2022 surveillance season and recent changes to our surveillance practice.

Methods: The RSC's pseudonymized primary care data, linked to hospital and other data, are held in the Oxford-RCGP Clinical Informatics Digital Hub, a Trusted Research Environment. We describe the RSC's cohort profile as of September 2021, divided into a Primary Care Sentinel Cohort (PCSC)-collecting virological and serological specimens-and a larger group of syndromic surveillance general practices (SSGPs). We report changes to our sampling strategy that brings the RSC into alignment with European Centre for Disease Control guidance and then compare our cohort's sociodemographic characteristics with Office for National Statistics data. We further describe influenza and COVID-19 vaccine coverage for the 2020-2021 season (week 40 of 2020 to week 39 of 2021), with the latter differentiated by vaccine brand. Finally, we report COVID-19-related outcomes in terms of hospitalization, intensive care unit (ICU) admission, and death.

Results: As a response to COVID-19, the RSC grew from just over 500 PCSC practices in 2019 to 1879 practices in 2021 (PCSC, n=938; SSGP, n=1203). This represents 28.6% of English general practices and 30.59% (17,299,780/56,550,136) of the population. In the reporting period, the PCSC collected >8000 virology and >23,000 serology samples. The RSC population was broadly representative of the national population in terms of age, gender, ethnicity, National Health Service Region, socioeconomic status, obesity, and smoking habit. The RSC captured vaccine coverage data for influenza (n=5.4 million) and COVID-19, reporting dose one (n=11.9 million), two (n=11 million), and three (n=0.4 million) for the latter as well as brand-specific uptake data (AstraZeneca vaccine, n=11.6 million; Pfizer, n=10.8 million; and Moderna, n=0.7 million). The median (IQR) number of COVID-19 hospitalizations and ICU admissions was 1181 (559-1559) and 115 (50-174) per week, respectively.

Conclusions: The RSC is broadly representative of the national population; its PCSC is geographically representative and its SSGPs are newly supporting UKHSA syndromic surveillance efforts. The network captures vaccine coverage and has expanded from reporting primary care attendances to providing data on onward hospital outcomes and deaths. The challenge remains to increase virological and serological sampling to monitor the effectiveness and waning of all vaccines available in a timely manner.

Keywords: COVID-19; cohort; cohort profile; computerized medical record systems; digital surveillance; general practice; health data; hospital; immunology; influenza; monitoring; outcome; primary care data; public health; representation; sampling; sentinel surveillance; serology; surveillance; syndromic surveillance; uptake; vaccination; virology; virus.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: As specified above, ML’s doctorate is partly funded by EMIS Health. MZ is a member of SAGE/NERVTAG/JCVI working/expert groups (unpaid positions) and chair of the charitable organization ISIRV (unpaid position). The Vaccine Evaluation Unit carries out contract research on behalf of UKHSA for GSK, Pfizer, and Sanofi. This is not directly related to the work in this publication. The Immunisation Department provides vaccine manufacturers (including Pfizer) with postmarketing surveillance reports about pneumococcal and meningococcal disease, which the companies are required to submit to the UK Licensing Authority in compliance with their Risk Management Strategy. A cost recovery charge is made for these reports. FDRH has also received occasional fees or expenses for speaking or consultancy on cardiovascular disease from AstraZeneca, BI, Bayer, BMS/Pfizer, and Novartis. SdL is the director of the RCGP-RSC; he has received vaccine-related research funding from AstraZeneca, GSK, Sanofi, Seqirus, and Takeda, and has been a member of advisory boards for AstraZeneca, Sanofi, and Seqirus. The other authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Data flow diagram for Oxford-Royal College of General Practitioners Clinical Information Digital Hub (ORCHID) Trusted Research Environment (TRE). Pale blue boxes represent the principal primary care data sources, pale yellow represents secondary data sources, and pale red represents data outputs. The dark blue box represents the data processing within the ORCHID TRE. Egton Medical Information Systems (EMIS) Health and The Phoenix Partnership (TPP) are primary care software services and act as data processors on behalf of National Health Service (NHS) primary care providers. INPS: In Practice Systems; ONS: Office for National Statistics; PCSC: Primary Care Sentinel Cohort; SNOMED-CT: Systematized Nomenclature of Medicine Clinical Terms; SSGP: syndromic surveillance general practices; UKHSA: UK Health Security Agency.
Figure 2
Figure 2
Age-sex pyramid of the Research and Surveillance Centre population on October 2021 compared to Office for National Statistics (ONS) estimates for 2019. F: female; M: male; ORCHID: Oxford-Royal College of General Practitioners Clinical Informatics Digital Hub.
Figure 3
Figure 3
Geographical distribution of Primary Care Sentinel Cohort (PCSC) practices (left panel) and syndromic surveillance general practice (SSGP) practices (right panel).
Figure 4
Figure 4
Absolute weekly vaccine uptake for seasonal influenza and COVID-19 doses over time. Data represent the entire Research and Surveillance Centre network population.
Figure 5
Figure 5
COVID-19 hospitalization data in the RSC network population, calculated using RSC data linked to Hospital Episode Statistics (HES) data. Left panel: Number of hospitalisations per week due to COVID-19. Right panel: Weekly hospital bed occupancy. An admission was defined as spending at least 1 night in hospital.
Figure 6
Figure 6
COVID-19 death data in the Research and Surveillance Centre (RSC) network population, calculated using RSC data linked to Office of National Statistics death data and COVID-19 Hospitalizations in England Surveillance System data. Most deaths occurring between October and December 2020 are not shown due to missing data. Left panel: All deaths. Middle panel: In-hospital deaths. Right panel: Out of hospital deaths.

Similar articles

Cited by

References

    1. de Lusignan S, Correa A, Smith GE, Yonova I, Pebody R, Ferreira F, Elliot AJ, Fleming D. RCGP Research and Surveillance Centre: 50 years' surveillance of influenza, infections, and respiratory conditions. Br J Gen Pract. 2017 Oct;67(663):440–441. doi: 10.3399/bjgp17X692645. https://bjgp.org/cgi/pmidlookup?view=long&pmid=28963401 67/663/440 - DOI - PMC - PubMed
    1. Elliot AJ, Fleming DM. Surveillance of influenza-like illness in England and Wales during 1966-2006. Euro Surveill. 2006;11(10):249–250.651 - PubMed
    1. Fleming DM, Elliot AJ. Lessons from 40 years' surveillance of influenza in England and Wales. Epidemiol Infect. 2008 Jul;136(7):866–875. doi: 10.1017/S0950268807009910.S0950268807009910 - DOI - PMC - PubMed
    1. de Lusignan S, Tsang RSM, Amirthalingam G, Akinyemi O, Sherlock J, Tripathy M, Deeks A, Ferreira F, Howsam G, Hobbs FDR, Joy M. Adverse events of interest following influenza vaccination, a comparison of cell culture-based with egg-based alternatives: English sentinel network annual report paper 2019/20. Lancet Reg Health Eur. 2021 Mar;2:100029. doi: 10.1016/j.lanepe.2021.100029. https://linkinghub.elsevier.com/retrieve/pii/S2666-7762(21)00006-5 S2666-7762(21)00006-5 - DOI - PMC - PubMed
    1. Whitaker HJ, Tsang RSM, Byford R, Andrews NJ, Sherlock J, Sebastian Pillai P, Williams J, Button E, Campbell H, Sinnathamby M, Victor W, Anand S, Linley E, Hewson J, DArchangelo S, Otter AD, Ellis J, Hobbs RFD, Howsam G, Zambon M, Ramsay M, Brown KE, de Lusignan S, Amirthalingam G, Lopez Bernal J. Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups. J Infect. 2022 May;84(5):675–683. doi: 10.1016/j.jinf.2021.12.044. https://europepmc.org/abstract/MED/34990709 S0163-4453(21)00664-2 - DOI - PMC - PubMed

Publication types